GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC12399 structure
    GC12399BMS345541 hydrochloride
    CAS: 547757-23-3
    Purity: >99.50%

    BMS345541 hydrochloride is an orally active and highly selective inhibitor of IκB kinase (IKK). BMS345541 hydrochloride inhibits IKK-2 (IC 50 =0.3μM) and IKK-1 (IC 50 =4μM).

  • GC12517 structure
    GC12517Sasapyrine
    CAS: 552-94-3
    Purity: >98.00%

    ساسابيرين ، ساليسيلات غير أسيتيل ، هو دواء فعال مضاد للروماتيزم يتخطى امتصاص المعدة ويتجنب أيضًا تثبيط انزيمات الأكسدة الحلقية.

  • GC12520 structure
    GC12520Diphenyleneiodonium chloride
    CAS: 4673-26-1
    Purity: >99.50%

    كلوريد ديفنيلين ايودونيوم (DPI) (DPIC) ، كمثبط لأكسدة NADH / NADPH ، يتمتع بنشاط مضاد للجراثيم قوية ضد Mtb و S. aureus.

  • GC12532 structure
    GC12532CHPG
    CAS: 170846-74-9
    Purity: >98.00%

    CHPG هو ناهض mGluR5 انتقائي ، ويخفف من الإجهاد التأكسدي والالتهاب الناجم عن SO2 من خلال مسار TSG-6 / NF-κB في الخلايا الدبقية الصغيرة BV2

  • GC12537 structure
    GC12537ATB-337
    CAS: 912758-00-0
    Purity: >98%

    ATB-337 هو جزيء هجين لمتبرع H2S وديكلوفيناك NSAID.

  • GC12544 structure
    GC12544Hydroxychloroquine Sulfate
    CAS: 747-36-4
    Purity: >99.50%

    مثبط الأوتوفاجي.

  • GC12555 structure
    GC12555GS-9620 (Vesatolimod)
    CAS: 1228585-88-3
    Purity: >99.50%

    GS-9620 (Vesatolimod) is a potent, orally active Toll-like receptor 7 (TLR7) agonist with an EC 50 value of 291nM, exhibiting antiviral activity.

  • GC12567 structure
    GC12567TRIM
    CAS: 25371-96-4
    Purity: >98%

    TRIM هو مثبط قوي سينثاز أكسيد النيتريك

  • GC12578 structure
    GC12578(R)-Lisofylline
    CAS: 100324-81-0
    Purity: >98.00%

    (R) -Lisofylline ((R) -Lisophylline) هو (R) -enantiomer لمستقلب البنتوكسيفيلين مع خصائص مضادة للالتهابات

  • GC12604 structure
    GC12604Fumonisin B1
    CAS: 116355-83-0
    Purity: >98.00%

    فومونيسين ب1 هو سم قاروري يتم إنتاجه من F. moniliforme، وهو فطر شائع في الذرة والحبوب الأخرى.

  • GC12609 structure
    GC12609PS 1145 dihydrochloride
    CAS: 1049743-58-9
    Purity: >98%

    PS-1145 (ثنائي هيدروكلوريد) هو مثبط قوي لـ IκB kinase-2 بقيمة IC50 تبلغ 88 نانومتر.

  • GC12628 structure
    GC12628ITE
    CAS: 448906-42-1
    Purity: >99.00%

    ITE هو ناهض داخلي قوي لمستقبلات أريل الهيدروكربونية (AhR) ، يرتبط مباشرة بـ AHR ، مع Ki من 3 نانومتر

  • GC12677 structure
    GC12677N-Benzylacetamidine (hydrobromide)
    CAS: 186545-76-6
    Purity: >98%

    iNOS inhibitor

  • GC12810 structure
    GC12810SR 11302
    CAS: 160162-42-5
    Purity: >98.00%

    SR 11302 is a retinoid-based, AP-1-selective transcription factor inhibitor that blocks AP-1 activity without activating retinoic acid response element (RARE)-mediated transcription.

  • GC12821 structure
    GC12821Oltipraz
    CAS: 64224-21-1
    Purity: >99.50%

    Oltipraz له تأثير مثبط على تنشيط HIF-1α بطريقة تعتمد على الوقت ، مما يلغي تمامًا تحريض HIF-1α عند تركيزات 10 ميكرومتر ، ويكون IC50 من Oltipraz لتثبيط HIF-1α هو 10 ميكرومترOltipraz هو منشط فعال Nrf2

  • GC12867 structure
    GC12867L-NIO dihydrochloride
    CAS: 159190-44-0
    Purity: >98%

    ثنائي هيدروكلوريد L-NIO هو مثبط سينثاز أكسيد النيتريك (NOS) قوي وغير انتقائي ومعتمد على NADPH ، مع Kis 1.7 ، 3.9 ، 3.9 ميكرومتر للخلايا العصبية (nNOS) ، البطانية (eNOS) ، ومحفز (iNOS) ، على التوالي

  • GC12928 structure
    GC12928Vinyl-L-NIO (hydrochloride)
    CAS: 728944-69-2
    Purity: >98%

    potent, selective inhibitor of nNOS

  • GC12943 structure
    GC12943STING agonist-1
    CAS: 702662-50-8
    Purity: >99.50%

    ناهض اللدغة -1 (G10) هو ناهض لدغة خاص بالإنسان ويحفز نشاطًا مضادًا للفيروسات ضد فيروسات ألفا الناشئة

  • GC13030 structure
    GC13030(R)-(-)-Ibuprofen
    CAS: 51146-57-7
    Purity: >99.50%

    (R) - (-) - ايبوبروفين هو R enantiomer من ايبوبروفين ، غير نشط على COX ، يمنع تنشيط NF-B ؛ (R) - (-) - ايبوبروفين يعرض تأثيرات مضادة للالتهابات ومضادة للألم

  • GC13035 structure
    GC13035Bay 11-7821
    CAS: 19542-67-7
    Purity: >95.00%

    Bay 11-7821 هو مثبط لفسفرة IκBα وNF-κB، يثبط بشكل إنتقائي وغير معكوسي فسفرة IκB-α المحفزة بـTNF-α (قيمة IC 50 حوالي 10μM)، ويقلل تعبير NF-κB وجزيئات الالتصاق. يثبط Bay 11-7821 الإنزيمات البروتيزية المحددة لليوبيكويتين USP7 وUSP21 مع قيم IC 50 بـ0.19 و0.96μM على التوالي.

  • GC13051 structure
    GC13051Lipoamide
    CAS: 940-69-2
    Purity: >98.00%

    Lipoamide ((±) -α-Lipoamide) هو أميد أحادي حمض الكربوكسيل الناتج عن التكثيف الرسمي لمجموعة الكربوكسي من حمض ليبويك مع الأمونيا

  • GC13058 structure
    GC13058NK 252
    CAS: 1414963-82-8
    Purity: >98.00%

    NK 252 عبارة عن منشط Nrf2 محتمل ، والذي يعرض إمكانات تنشيط Nrf2 كبيرة.

  • GC13074 structure
    GC13074HU 211
    CAS: 112924-45-5
    Purity: >98%

    NMDA antagonist, novel and non-competitive

  • GC13127 structure
    GC131274-Nitroquinoline N-oxide
    CAS: 56-57-5
    Purity: >98.00%

    4-Nitroquinoline N-oxide is a potent mutagenic and carcinogenic compound that induces DNA damage and oxidative stress, making 4-Nitroquinoline N-oxide an important tool for cancer research and the study of DNA repair mechanisms.